Fill-Finish Inspection AI

Add a real-time inspection layer to every container on the line with Vision AI for fill-finish inspection. Built for the cGMP environments where one missed fill volume error, mis-seated stopper, breached crimp seal, or unflagged particulate can mean a recall, an FDA 483, a batch rejection at final review, or harm to a patient. Whether you're inspecting clear vials, lyophilized vials, ampoules, prefilled syringes, cartridges, or IV bags across fill, stoppering, capping, AVI, labeling, and final pack-out, Roboflow extends your QC coverage to every container on the line, on the cameras and inspection stations your facility already runs, validatable under USP <790>, FDA 21 CFR Part 11, and EU GMP Annex 1.

Fill, Stopper, and Crimp Seal Verification:

• Verify fill volume and headspace across vials, ampoules, prefilled syringes, and cartridges
• Inspect stopper and plunger seating, dimple position, and rubber integrity
• Catch crimp seal defects, missing caps, and tamper-evident closure issues before AVI

Particulate, Cosmetic, and Drug Appearance Inspection:

• Detect visible particulates per USP <790>, including glass fragments, fibers, stopper material, and protein aggregates
• Identify glass cosmetic defects (cracks, chips, scratches, delamination) on vials and ampoules
• Inspect lyophilized cake structure, color, and reconstitution appearance on finished product

Label, Pack-Out, and Compliance:

• Verify labels, lot codes, expiration dates, and 2D codes on every container
• Check carton, blister, and shipper assembly for completeness and orientation
• Maintain a validated audit trail for every container per FDA 21 CFR Part 11 and EU GMP Annex 11

Bring intelligence to every container today. Stop fill-finish defects from becoming 483s, recalls, or batch rejections.

‍

Frequently asked questions

What is fill-finish inspection with Vision AI?

Fill-finish inspection with Vision AI uses computer vision models to inspect parenteral drug products at every stage of the fill-finish process, from container preparation through filling, stoppering, capping, automated visual inspection (AVI), labeling, and final pack-out. The system extends QC coverage to every vial, ampoule, prefilled syringe, cartridge, and IV bag on the line, catching fill volume errors, stopper and plunger seating issues, crimp seal defects, visible particulates, glass cosmetic flaws, lyophilized cake anomalies, and label and pack-out errors. Pharma manufacturers use it to cut scrap, reduce false rejects, protect batch release timelines, and document compliance under USP <790>, FDA 21 CFR Part 211 (cGMP), and EU GMP Annex 1.

Can Vision AI inspect fill volume, stopper seating, and crimp seal integrity across vials, ampoules, and PFS?

Yes, and these are exactly the inspection tasks where deep learning extends traditional fill-finish AVI most. Fill volume and headspace verification, stopper and plunger seating, dimple position, and crimp seal integrity all share a common challenge, the defect signature varies lot to lot with drug formulation viscosity, stopper material, glass batch, and fill-line speed. Roboflow models can be trained against your specific acceptance criteria for each container type and inspection stage, with edge-optimized models that run at line speed and flag suspect units for trained inspector adjudication. The system applies the same pass/fail logic your trained inspectors would, against your written specifications, and produces a validated inspection record for every container that holds up to FDA, EMA, and notified body audit scrutiny.

Does fill-finish inspection support USP <790>, EU GMP Annex 1, and FDA 21 CFR Part 11?

Yes. Roboflow models can be trained against your specific USP <790> (Visible Particulates in Injections), USP <1790> (Visual Inspection of Injectable Drug Products guidance), EU GMP Annex 1 (Manufacture of Sterile Products), and FDA 21 CFR Part 11 (Electronic Records and Electronic Signatures) inspection criteria. The system also supports USP <788> (Particulate Matter in Injections), USP <787> (Subvisible Particulate Matter in Therapeutic Protein Injections), EP 2.9.20 (Particulate Contamination), and JP 6.06 (Foreign Insoluble Matter Test for Injections) acceptance criteria. It produces a validated inspection record for every container that supports your FDA, EMA, MHRA, and PMDA regulatory submissions, batch release documentation, and audit response packets. Your quality and regulatory teams own the acceptance criteria; Roboflow provides the inspection engine that enforces them at line speed.

Can it integrate with our existing AVI line, MES, eQMS, and validation workflow?

Yes. Roboflow Inference exposes a standard API and supports common pharma manufacturing protocols, so Vision AI fill-finish inspection events flow into your existing AVI line equipment, MES, eQMS, EBR, and validation workflow. Roboflow can deploy alongside existing AVI lines from Seidenader (Korber), Bosch / Syntegon, Brevetti CEA, Antares Vision, and Stevanato Group, adding a deep-learning layer to the rule-based vision systems already in production, or run as the primary inspection on new lines. Customers integrate with MasterControl, Veeva Vault QMS, Sparta TrackWise, Werum PAS-X (EBR and MES), SAP, and custom GMP platforms through REST, MQTT, OPC UA, and direct database writes. Models are designed to be validatable under FDA 21 CFR Part 11 with IQ/OQ/PQ-ready documentation, audit trails for training data, model versions, and inspection results that pass validation engineer review and FDA audit scrutiny.

‍